BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lung cancer AND PIK3R1, P27986, 5295, ENSG00000145675, p85-ALPHA, GRB1 AND Treatment
12 results:

  • 1. Identification of multiple organ metastasis-associated hub mRNA/miRNA signatures in non-small cell lung cancer.
    Zu L; He J; Zhou N; Tang Q; Liang M; Xu S
    Cell Death Dis; 2023 Dec; 14(12):798. PubMed ID: 38057344
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Determining the mechanism of action of the Qishan formula against lung adenocarcinoma by integration of network pharmacology, molecular docking, and proteomics.
    Geng X; Chi W; Lin X; Niu Z; Jiang Q; Sui Y; Jiang J
    Medicine (Baltimore); 2023 Mar; 102(13):e33384. PubMed ID: 37000102
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Molecular Genetic Landscape of Sclerosing Pneumocytomas.
    Boland JM; Lee HE; Barr Fritcher EG; Voss JS; Jessen E; Davila JI; Kipp BR; Graham RP; Maleszewski JJ; Yi ES
    Am J Clin Pathol; 2021 Feb; 155(3):397-404. PubMed ID: 33145590
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Restoration of mutant K-Ras repressed miR-199b inhibits K-Ras mutant non-small cell lung cancer progression.
    Jin H; Jang Y; Cheng N; Li Q; Cui PF; Zhou ZW; Jiang HL; Cho MH; Westover KD; Tan QY; Xu CX
    J Exp Clin Cancer Res; 2019 Apr; 38(1):165. PubMed ID: 30987652
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Trans-3,5,4ยด-trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498.
    Lu M; Liu B; Xiong H; Wu F; Hu C; Liu P
    J Cell Mol Med; 2019 Apr; 23(4):2431-2441. PubMed ID: 30701693
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. RAF inhibitor LY3009120 sensitizes RAS or BRAF mutant cancer to CDK4/6 inhibition by abemaciclib via superior inhibition of phospho-RB and suppression of cyclin D1.
    Chen SH; Gong X; Zhang Y; Van Horn RD; Yin T; Huber L; Burke TF; Manro J; Iversen PW; Wu W; Bhagwat SV; Beckmann RP; Tiu RV; Buchanan SG; Peng SB
    Oncogene; 2018 Feb; 37(6):821-832. PubMed ID: 29059158
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. MicroRNA-Related Polymorphisms in PI3K/Akt/mTOR Pathway Genes Are Predictive of Limited-Disease Small Cell lung cancer treatment Outcomes.
    Jiang W; Zhang W; Wu L; Liu L; Men Y; Wang J; Liang J; Hui Z; Zhou Z; Bi N; Wang L
    Biomed Res Int; 2017; 2017():6501385. PubMed ID: 28280736
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Gene expression profiling of lung adenocarcinoma in Xuanwei, China.
    Wu H; Meng S; Xu Q; Wang X; Wang J; Gong R; Song Y; Duan Y; Zhang Y
    Eur J Cancer Prev; 2016 Nov; 25(6):508-17. PubMed ID: 26695082
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance.
    Saunus JM; Quinn MC; Patch AM; Pearson JV; Bailey PJ; Nones K; McCart Reed AE; Miller D; Wilson PJ; Al-Ejeh F; Mariasegaram M; Lau Q; Withers T; Jeffree RL; Reid LE; Da Silva L; Matsika A; Niland CM; Cummings MC; Bruxner TJ; Christ AN; Harliwong I; Idrisoglu S; Manning S; Nourse C; Nourbakhsh E; Wani S; Anderson MJ; Fink JL; Holmes O; Kazakoff S; Leonard C; Newell F; Taylor D; Waddell N; Wood S; Xu Q; Kassahn KS; Narayanan V; Taib NA; Teo SH; Chow YP; kConFab ; Jat PS; Brandner S; Flanagan AM; Khanna KK; Chenevix-Trench G; Grimmond SM; Simpson PT; Waddell N; Lakhani SR
    J Pathol; 2015 Nov; 237(3):363-78. PubMed ID: 26172396
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. A dedicated microarray for in-depth analysis of pre-mRNA splicing events: application to the study of genes involved in the response to targeted anticancer therapies.
    Pesson M; Eymin B; De La Grange P; Simon B; Corcos L
    Mol Cancer; 2014 Jan; 13():9. PubMed ID: 24428911
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. VEGFA upregulates FLJ10540 and modulates migration and invasion of lung cancer via PI3K/AKT pathway.
    Chen CH; Lai JM; Chou TY; Chen CY; Su LJ; Lee YC; Cheng TS; Hong YR; Chou CK; Whang-Peng J; Wu YC; Huang CY
    PLoS One; 2009; 4(4):e5052. PubMed ID: 19337377
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. A gene expression signature predicts survival of patients with stage I non-small cell lung cancer.
    Lu Y; Lemon W; Liu PY; Yi Y; Morrison C; Yang P; Sun Z; Szoke J; Gerald WL; Watson M; Govindan R; You M
    PLoS Med; 2006 Dec; 3(12):e467. PubMed ID: 17194181
    [TBL] [Abstract] [Full Text] [Related]  


    of 1.